Skip to main content
SpringerLink
Log in

Methotrexate

  • Chapter
Extravasation of Cytotoxic Agents

  • 958 Accesses

Abstract

1. Stop injection/infusion immediately

2. Get extravasation kit

3. Put on (sterile) gloves

4. Replace infusion lead or syringe with 5 ml disposable syringe and aspirate slowly as much as possible of the extravasated drug; Cave! do not exert pressure on extravasation area

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Original articles

  1. Upton J, Mulliken JB, Murray JE: Major intravenous extravasation injuries. Am J Surg 137: 497–506, 1979.

    Article  PubMed  CAS  Google Scholar 

  2. Gluck-Kuyt I, Irwin LE: Anaphylactic reaction to high-dose methotrexate. Cancer Treat Rep 63: 797–798, 1979.

    PubMed  CAS  Google Scholar 

  3. Goldberg NH, Romolo JL, Austin EH, et al: Anaphylactoid type reactions in two patients receiving high dose intravenous methotrexate. Cancer 41: 52–55, 1978.

    Article  PubMed  CAS  Google Scholar 

  4. Barr RD, Benton SG, Belbeck LW: Soft-tissue necrosis induced by extravasated cancer chemotherapeutic agents. J Natl Cancer Inst 66: 1129–1136, 1981.

    PubMed  CAS  Google Scholar 

  5. Krämer I: Zehn Jahre Dokumentation von Zytostatika-Paravasat-Ereignissen: Auswertung von 175 Paravasate-Dokumentationen. Krankenhauspharmazie 23: 269–274, 2002.

    Google Scholar 

  6. Ang TS, Siderov J: Extravasation of high-dose methotrexate: a case of nothing. Aust J Hosp Pharm 28: 430–431, 1998.

    Google Scholar 

Secondary literature

  1. Dorr RT: Pharmacologic management of vesicant chemotherapy extravasations. In: Dorr RT, Von Hoff DD (eds) Cancer Chemotherapy Handbook. Appleton & Lange, 2nd edition: 109–118, 1994.

    Google Scholar 

  2. Stanley A: Managing complications of chemotherapy administration. In: Allwood M, Stanley A, Wright P (eds) The Cytotoxics Handbook. Radcliffe Medical Press, 4th edition: 119–193, 2002.

    Google Scholar 

  3. Schneider G: Paravasate von Zytostatika. Diagnostik und Therapie. Aina S. Schneider Verlag, 6th edition: 1–17, 1999.

    Google Scholar 

  4. Gain M, Melzer S, Meyer-Jürshof A, et al: Allgemeiner Teil: Behandlung von Paravasaten. In: Gain M, et al (eds) ADKA-Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, vol 1, 2nd edition: A42–44, 1997.

    Google Scholar 

  5. Cox K, Stuart-Harris R, Abdini G, et al: The management of cytotoxic-drug extravasation: guide-lines drawn up by a working party for the Clinical Oncological Society of Australia. Med J Aust 148: 185–189, 1988.

    PubMed  CAS  Google Scholar 

  6. Ignoffo RJ, Friedman MA: Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev 7: 17–27, 1980.

    Article  PubMed  CAS  Google Scholar 

  7. Summary of product characteristics. Methotrexat “Ebewe” 10 mg/ml (Austria), Ebewe, July 2004.

    Google Scholar 

  8. Schneider SM, Distelhorst CW: Chemotherapy-induced emergencies. Semin Oncol 16: 572–578, 1989.

    PubMed  CAS  Google Scholar 

  9. Berdel WE, Schmoll HJ, Büchele T, et al: Prävention und Therapie von Paravasaten/Extravasaten. In: Schmoll HJ, Höffken K, Possinger K (eds) Kompendium Internistische Onkologie. Standards in Diagnostik und Therapie. Springer, vol 1, 3rd edition: 1689–1701, 1999.

    Google Scholar 

  10. Donislawski S, Gain M, Meyer-Jürshof A, et al: Methotrexat: Behandlung von Paravasaten. In: Donislawski S, et al (eds) ADKA-Zytostatika-Handbuch, Pharmazeutisch-wissenschaftliche Monographien. Verlag Heiner Biller, vol 2: 43, 1994.

    Google Scholar 

  11. Dorr RT, Von Hoff DD: Drug monographs: methotrexate. In: Dorr RT, Von Hoff DD (eds) Cancer Chemotherapy Handbook. Appleton & Lange, 2nd edition: 692–705, 1994.

    Google Scholar 

  12. Dorr RT: Antidotes to vesicant chemotherapy extravasations. Blood Rev 4: 41–60, 1990.

    Article  PubMed  CAS  Google Scholar 

  13. Barth J: Paravasate und deren Behandlung. In: Barth J (ed) Zytostatika-Herstellung in der Apotheke. Deutscher Apotheker Verlag, chapter VI-3: 1–9, 2000.

    Google Scholar 

  14. Jordan K, Grothe W, Schmoll HJ: Paravasation von Zytostatika: Prävention und Therapie. Dtsch Med Wochenschr 130: 33–37, 2005.

    Article  PubMed  CAS  Google Scholar 

  15. Krämer I, Stützle M: Zytostatika-Paravasation – Wie ist vorzugehen? Krankenhauspharmazie 23: 261–268, 2002.

    Google Scholar 

  16. Koppel RA, Boh EE: Cutaneous reactions to chemotherapeutic agents. Am J Med Sci 321: 327–335, 2001.

    Article  PubMed  CAS  Google Scholar 

  17. Alley E, Green R, Schuchter L: Cutaneous toxicities of cancer therapy. Curr Opin Oncol 14: 212–216, 2002.

    Article  PubMed  CAS  Google Scholar 

  18. Otto J, Goebell PJ, Otto T: Urologischer Notfall in der Onkologie. Der Onkologe 10: 351–357, 2004.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CRETA – Cancer Research & Trial Agency GmbH, Bad Sauerbrunn, Österreich

    Ines Mader MD

  2. Krankenhaus und Geriatriezentrum, SMZ Floridsdorf, Wien, Österreich

    Mag. pharm. Patrizia Fürst-Weger

  3. Klinische Abteilung für Onkologie, Univ.-Klinik für Innere Medizin I, Wien, Österreich

    Univ.-Prof. Dr. Robert Mader

  4. Anstaltsapotheke, Landeskrankenhaus – Universitätskliniken Innsbruck, Innsbruck, Österreich

    Mag. pharm. Dr. Elisabeth Nogler-Semenitz

  5. Apotheke LKH-Univ.-Klinikum Graz, Graz, Österreich

    Mag. pharm. Sabine Wassertheurer

Authors
  1. Ines Mader MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mag. pharm. Patrizia Fürst-Weger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Univ.-Prof. Dr. Robert Mader
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mag. pharm. Dr. Elisabeth Nogler-Semenitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mag. pharm. Sabine Wassertheurer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag/Wien

About this chapter

Cite this chapter

Mader, I., Fürst-Weger, P., Mader, R., Nogler-Semenitz, E., Wassertheurer, S. (2010). Methotrexate. In: Extravasation of Cytotoxic Agents. Springer, Vienna. https://doi.org/10.1007/978-3-211-88893-3_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-88893-3_43

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-88889-6

  • Online ISBN: 978-3-211-88893-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation